Dyspareunia affects women of all ages with cancer, so assess pain location, intensity, and dryness, as well as partner ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Newer therapies improve inflammatory rosacea, yet additional research is needed to help clinicians manage vascular, ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

Benzodiazepine use during pregnancy is associated with a 20% higher risk for preterm birth and a 6% increased risk for small ...

Individuals with type 2 diabetes and painful symptomatic knee osteoarthritis are less likely to achieve target glycemic ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and ...

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

Replacing aspirin with a P2Y12 inhibitor soon after coronary stenting is tied to a higher ischemic risk than dual antiplatelet therapy in the first 30 days, but not later, in acute coronary syndrome.

Prof David Kerr breaks down a study comparing dexterity across hospital staff, revealing how surgeons and physicians stack up ...